CVS Releases 2018 Formulary Drug List with an Outcomes-based Management Program
On Wednesday, CVS Health (one of the largest PBMs) announced its standard control formulary for 2018 with an outcomes-based management
Read More
Part D/Prescription Drugs
4 steps to reversing the epidemic of opioid use disorders
(By Brian D. Sites and Matthew A. Davis for STAT) Health care professionals share a common and lofty goal: to
Read MoreDrug Puts A $750,000 ‘Price Tag On Life’
(By Julie Appleby for Kaiser Health News) Jana Gundy and Amanda Chaffin live within two hours of each other in
Read MorePrescription opioid use is widespread. Here’s who is most vulnerable to misuse
(By Megan Thielking for STAT) Nearly 92 million adults in the United States used prescription opioids in 2015 — and
Read MoreExpress Scripts Releases 2018 Formulary Drug List
Express Scripts, one of the largest Pharmacy Benefit Manager in United States, released their formulary drug list for 2018 increasing
Read MoreWhat You Need to Know Before Your Medicare Benefits Start
Medicare is the most widely used health insurance plan in the United States but most pre-retirees do not understand it.
Read MoreFDA head seeks unlikely allies in opioid fight: Insurers and PBMs
(By Brian Zimmerman for Becker’s Hospital Review) Scott Gottlieb, MD, commissioner of the Food and Drug Administration, plans to meet
Read MoreMany pharma transparency policies are vague, ambiguous, and contradictory
(By Ed Silverman for STAT) After several years in which drug makers have been pressured to release clinical trial data,
Read MoreAdding ‘right to try’ to FDA user fee bill would undermine the agency’s work
(By Kelly McBride Folkers for STAT) As Congress renegotiates the FDA Reauthorization Act, a must-pass piece of legislation that lets
Read MoreFollow The Money: Drugmakers Deploy Political Cash As Prices And Anger Mount
(By Jay Hancock and Elizabeth Lucas and Sydney Lupkin for Kaiser Health News) Two federal investigations — one examining opioid
Read More